Segment disclosures

Company overview

HEALTHY EXTRACTS INC.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

5 dimension combinations 29 retained observations 16 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Advertising

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=grck:AdvertisingMember
PeriodValueUnitFiledEvidence
2017-01-01 – 2017-12-31120500 USD20180608Open filing evidence

CBD

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=grck:CBDMember
PeriodValueUnitFiledEvidence
2018-07-01 – 2018-09-3015203 USD20190425Open filing evidence
2018-01-01 – 2018-09-3066119 USD20190425Open filing evidence
2018-04-01 – 2018-06-3031060 USD20180911Open filing evidence
2018-01-01 – 2018-06-3050916 USD20180911Open filing evidence
2018-01-01 – 2018-03-3119856 USD20180713Open filing evidence
2017-01-01 – 2017-12-317605 USD20180608Open filing evidence

Health Supplements

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=grck:HealthSupplementsMember
PeriodValueUnitFiledEvidence
2020-01-01 – 2020-03-31455839 USD20200814Open filing evidence
2019-01-01 – 2019-12-31748377 USD20200810Open filing evidence
2019-07-01 – 2019-09-30273302 USD20200601Open filing evidence
2019-01-01 – 2019-09-30571615 USD20200601Open filing evidence
2019-04-01 – 2019-06-30201040 USD20200529Open filing evidence
2019-01-01 – 2019-06-30298313 USD20200529Open filing evidence
2019-01-01 – 2019-03-3197273 USD20200528Open filing evidence

Health Supplements · Berga Met

Statement Business Segments · Business Acquisition

Source dimensions us-gaap:StatementBusinessSegmentsAxis=grck:HealthSupplementsMember;us-gaap:BusinessAcquisitionAxis=grck:BergaMetMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-03-31170433 USD20210514Open filing evidence
2020-10-01 – 2020-12-31135902 USD20210219Open filing evidence
2020-01-01 – 2020-12-311276559 USD20210219Open filing evidence
2020-07-01 – 2020-09-30533099 USD20201029Open filing evidence
2020-01-01 – 2020-09-301140657 USD20201029Open filing evidence
2020-04-01 – 2020-06-30151719 USD20200915Open filing evidence
2020-01-01 – 2020-06-30607558 USD20200915Open filing evidence

Health Supplements · Berga Met

Statement Business Segments · Business Acquisition

Source dimensions us-gaap:StatementBusinessSegmentsAxis=hyex:HealthSupplementsMember;us-gaap:BusinessAcquisitionAxis=hyex:BergaMetMember
PeriodValueUnitFiledEvidence
2021-10-01 – 2021-12-31766372 USD20220401Open filing evidence
2021-01-01 – 2021-12-311676598 USD20220401Open filing evidence
2021-07-01 – 2021-09-30447986 USD20211115Open filing evidence
2021-04-01 – 2021-09-30903142 USD20211115Open filing evidence
2021-01-01 – 2021-06-30414318 USD20210903Open filing evidence
2021-01-01 – 2021-03-31170433 USD20210803Open filing evidence
2020-10-01 – 2020-12-31135902 USD20210803Open filing evidence
2020-01-01 – 2020-12-311276559 USD20210803Open filing evidence